Hosted on MSN
Syncom Formulations (India) Ltd Reports Stellar Growth in Q4 and FY 2024-25 Results; Profit After Tax Surges by 139%
Syncom Formulations (India) Limited, a leading name in the Indian pharmaceutical sector specialising in high-quality pharmaceutical formulations, has announced an outstanding performance for the ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results